News

Stay up to date with trenzyme’s latest news. Here you can find and read current news and press releases about us as well as our cell line and protein services.

Press Releases

trenzyme GmbH unterstützt COVID-19 Forschung

trenzyme GmbH offers recombinant SARS-CoV-2 S1 protein to support Coronavirus research

Konstanz, March 11, 2020–  The 2019 novel coronavirus SARS-CoV-2 has caused an outbreak of the respiratory illness COVID-19 that started in China and has now spread throughout the world. Meanwhile, the spread of coronavirus has a strong impact on our daily life and the World Health Organization (WHO) has declared a global health emergency to gather resources to fight against this threat.

trenzyme GmbH Licenses SEFEX Cell Line Technology from Celonic AG

trenzyme GmbH Licenses SEFEX Cell Line Technology from Celonic AG

Basel, Switzerland, and Konstanz, Germany, October 6, 2015 / B3C newswire / –  Konstanz based contract research organization trenzyme GmbH and Basel based Celonic AG today announced the closure of a licence agreement on Celonics CHO-K1 based cell line expression platform SEFEX. Under the terms of the deal, trenzyme acquires the non-exclusive rights and know-how on this technology to establish high performance cell lines for R&D and GMP production purposes for its clients.

Zelllinien und Proteine vom Bodensee zur Erforschung moderner Medikamente

Zelllinien und Proteine vom Bodensee zur Erforschung moderner Medikamente

Biotechnologie-Unternehmen trenzyme wird 15, Konstanz, 27.04.2015 –  Als Hochschulausgründung aus der Universität Konstanz hervorgegangen, liefert die Konstanzer trenzyme GmbH heute mit großem Erfolg Bausteine für die Forschung und Entwicklung weltweit führender Pharmakonzerne. Das Unternehmen fertigt Proteine und modifizierte Zelllinien für die Entwicklung biotechnologisch hergestellter Arzneimittel, die sogenannten Biopharmazeutika; ein Handwerkszeug, das europaweit nur wenige liefern. In diesem Jahr feiert trenzyme sein 15-jähriges Bestehen.

News

Yvonne Heim, M.Sc.

Yvonne Heim, M.Sc.

Inside Sales & Marketing Manager

Yvonne is happy to help you as your personal contact regarding news releases or external communication.

Get In Contact With Us






By submitting this form, I consent to trenzyme GmbH receiving and processing my data in order to process my inquiry. My consent is voluntary and I may revoke this consent at any time without providing any reasons, e.g. by sending an email to privacy(at)trenzyme.com with effect for the future. Further notices on data processing can be found in our privacy policy.